title: Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome.
abstract: We present the case of a 29.5-year-old girl with Down's syndrome, type 1 diabetes mellitus (DMT1), autoimmune thyroiditis and celiac disease starting on insulin pump therapy. After 22-month follow-up hemoglobin A1c dropped from 9% to 6.8%, even with a lower insulin requirement and no change in BMI.
authors: Department of Pediatrics, Azienda Ospedaliera, University of Milan, Ospedale Luigi Sacco, Milan, Italy. scaramuzza.andrea@hsacco.it
authors: Andrea E
authors: AE
authors: Scaramuzza
authors: Elisa
authors: E
authors: Giani
authors: Sara
authors: S
authors: Riboni
authors: Daniele
authors: D
authors: Spiri
authors: Alessandra
authors: A
authors: De Palma
authors: Chiara
authors: C
authors: Mameli
authors: Gian Vincenzo
authors: GV
authors: Zuccotti
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000188:drug therapy*; D004314:Down Syndrome / Q000150:complications*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D050031:Hashimoto Disease / Q000150:complications; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069036:Insulin Glargine; D007332:Insulin Infusion Systems; D049528:Insulin, Long-Acting; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting